610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma

• Shailender Bhatia,
• Ramesh Rengan,
• Sylvia M Lee,
• Scott S Tykodi,
• Jing Zeng,
• Mary Redman,
• Peter H Goff,
• Kelsey K Baker

Affiliations

Shailender Bhatia

1University of Washington, Seattle, WA, USA

Ramesh Rengan

Aff2 grid.34477.330000000122986657Department of Radiation OncologyUniversity of Washington School of Medicine Seattle WA USA

Sylvia M Lee

Aff1 grid.270240.30000000121801622Clinical Research DivisionD3-100 Fred Hutchinson Cancer Research Center 1100 Fairview Ave 98109 Seattle WA USA

Scott S Tykodi

1University of Washington, Seattle, WA, USA

Jing Zeng

Department of Chronic Noncommunicable Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan, China

Mary Redman

4Fred Hutchinson Cancer Research Center, Seattle, WA, United States

Peter H Goff

1University of Washington, Seattle, WA, USA

Kelsey K Baker

2Fred Hutchinson Cancer Center, Seattle, WA, USA